Kyverna Therapeutics (KYTX) Q4 2024 Earnings

Nov 13Confirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-20.54
-13.91
-7.29
-0.67

Details

Expected EPS
-0.814276
Actual EPS
-0.8
Surprise EPS
0.01
Surprise Percent
+1.75%

Description

⁨Kyverna Therapeutics⁩ (⁦KYTX⁩) has reported earnings of ⁦-0.8⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts